Related News
MSD opens US$120m Hangzhou plant
By Ding Yining |
April 16, 2013, Tuesday
|
Online Edition
Online Edition
MSD China yesterday unveiled a US$120 million new plant in Hangzhou.
This is to secure pharmaceutical products supply in the region as the drug company taps the growing demand in China.
The Hangzhou new plant, located in the Hangzhou Economic & Technological Development Area, is the largest manufacturing base in the Asia Pacific region for MSD.
It is equipped with the highest level facilities with 16 high-speed production lines and has an estimated 300 million unit packing capacity annually.
"The Hangzhou new plant marks another milestone for MSD and we're seeking to bring more innovative medicines and vaccines to China," said Pam Cheng, president of MSD China.
The US drug maker has more than 90 production sites worldwide and the new opening will play a key role in the firm's global manufacturing chain.
"It also extends our long-standing partnership with the Chinese government, and our commitment to help broaden access to quality health care throughout China," Willie Deese, president of Merck Manufacturing Division, said at the opening ceremony for the Hangzhou factory.
The new facility will join an interdependent network of 72 MSD facilities that supply medicines and vaccines to more than 140 countries.
This is to secure pharmaceutical products supply in the region as the drug company taps the growing demand in China.
The Hangzhou new plant, located in the Hangzhou Economic & Technological Development Area, is the largest manufacturing base in the Asia Pacific region for MSD.
It is equipped with the highest level facilities with 16 high-speed production lines and has an estimated 300 million unit packing capacity annually.
"The Hangzhou new plant marks another milestone for MSD and we're seeking to bring more innovative medicines and vaccines to China," said Pam Cheng, president of MSD China.
The US drug maker has more than 90 production sites worldwide and the new opening will play a key role in the firm's global manufacturing chain.
"It also extends our long-standing partnership with the Chinese government, and our commitment to help broaden access to quality health care throughout China," Willie Deese, president of Merck Manufacturing Division, said at the opening ceremony for the Hangzhou factory.
The new facility will join an interdependent network of 72 MSD facilities that supply medicines and vaccines to more than 140 countries.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 娌狪CP璇侊細娌狪CP澶05050403鍙-1
- |
- 浜掕仈缃戞柊闂讳俊鎭湇鍔¤鍙瘉锛31120180004
- |
- 缃戠粶瑙嗗惉璁稿彲璇侊細0909346
- |
- 骞挎挱鐢佃鑺傜洰鍒朵綔璁稿彲璇侊細娌瓧绗354鍙
- |
- 澧炲肩數淇′笟鍔＄粡钀ヨ鍙瘉锛氭勃B2-20120012
Copyright 漏 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
